We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+4.47%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$425M
AUM Growth
-$75.9M
Cap. Flow
-$88.8M
Cap. Flow %
-20.87%
Top 10 Hldgs %
54.69%
Holding
34
New
5
Increased
6
Reduced
22
Closed
1

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$9.37M
2
CI icon
Cigna
CI
+$8.82M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$7.6M
4
INCY icon
Incyte
INCY
+$5.13M
5
BNTX icon
BioNTech
BNTX
+$3.57M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$26.8M
2
BAX icon
Baxter International
BAX
+$19.1M
3
PFE icon
Pfizer
PFE
+$18.1M
4
XRAY icon
Dentsply Sirona
XRAY
+$7.51M
5
QGEN icon
Qiagen
QGEN
+$7.21M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UHS icon
26
Universal Health Services
UHS
$9.12B
$5.87M 1.38%
45,238
-5,057
-10% -$650K
SAGE
27
DELISTED
Sage Therapeutics
SAGE
$4.21M 0.99%
98,904
-11,863
-11% -$497K
RIGL icon
28
Rigel Pharmaceuticals
RIGL
$734M
$3.89M 0.92%
146,960
-30,313
-17% -$915K
MRTX
29
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$3.83M 0.9%
26,106
+106
+0.4% +$16.5K
PDCO
30
DELISTED
Patterson Companies, Inc.
PDCO
$3.61M 0.85%
122,947
-47,600
-28% -$1.49M
BNTX icon
31
BioNTech
BNTX
$23.3B
$3.36M 0.79%
+13,032
New +$3.57M
NVAX icon
32
Novavax
NVAX
$1.3B
$1.91M 0.45%
13,346
+2,302
+21% +$396K
VIR icon
33
Vir Biotechnology
VIR
$1.56B
$1.84M 0.43%
+44,000
New +$1.72M
BAX icon
34
Baxter International
BAX
$11.4B
– –
-237,429
Closed -$19.1M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q4 2021 Portfolio in Review

As of Q4 2021, Sector Gamma AS held 34 positions worth $425M, down 15% from $501M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Sector Gamma AS withdrew a net $88.8M in Q4 2021, closing 1 position and reducing 22 holdings. Its most notable exit was Baxter International, an estimated $19.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Sector Gamma AS opened a new position in BioMarin Pharmaceuticals worth $10M.

  • Sector Gamma AS's largest Q4 2021 buy was BioMarin Pharmaceuticals: 113,548 shares worth $10M.
  • Sector Gamma AS added most to Incyte in Q4 2021, an estimated $5.13M increase.
  • Sector Gamma AS's biggest Q4 2021 reduction was Merck, cutting an estimated $26.8M.
  • Sector Gamma AS fully exited Baxter International in Q4 2021, selling an estimated $19.1M.
  • Sector Gamma AS's ten largest holdings make up 55% of its $425M portfolio in Q4 2021.
  • Sector Gamma AS opened 5 new positions and closed 1 in Q4 2021.
  • Sector Gamma AS's portfolio value fell 15% quarter-over-quarter to $425M.

Based on Sector Gamma AS's 13F filing for Q4 2021, filed 8 Feb 2022.